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ABSTRACT 
Objective: A simple, rapid and reproducible HPLC method was developed for the determination of bisoprolol in experimental combined dosage 
forms containing bisoprolol and enalapril and for drug dissolution studies. 
Methods: A C
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Keywords: bisoprolol, high-performance liquid chromatography, validation, dissolution study 
column (Hi Qsil C18, 5 μm, 4.6х250 mm ) and a mobile phase methanol: phosphate buffer solution (65:35, v/v) mixture were used 
for separation and quantification. Analyses were run at a flow rate of 1.0 ml/min and at ambient temperature. The injection volume was 300 μL and 
the ultraviolet detector was set at 225 nm. The method was validated as per ICH guidelines. 
Results: Under these conditions, bisoprolol was eluted at 4.75 min. Total run time was shorter than 6 min. A linear relationship between the 
concentration and the area of chromatographic peaks of bisoprolol in the range of 0.625 mg/ml-5.000 mg/ml (3.750 mg/ml at pH 1.2) has been 
established. In the medium with pH 1.2 release of bisoprolol from tablets in 5 min is 38.42%, and after 15 min-85.51%, in medium with pH 4.5 the 
release of bisoprolol from tablets in 5 min makes 59.78%, and after 15 min-103.71%; in a medium with pH 6.8, the release of bisoprolol from tablets 
in 5 min is 61.29%, and after 15 min-85.90%.  
Conclusion: The developed method was applied successfully for quality control assay of bisoprolol in experimental tablets and in vitro dissolution studies.  




A comparative dissolution kinetics test is a study whose purpose is to 
confirm the dissolution of the investigated drug in reference lens, in 
environments close to the gastrointestinal tract. Сomparative dissolution 
kinetics test is used to confirm the equivalence of the drug, while the 
Dissolution test is used to determine the quality of the drug. Сomparative 
dissolution kinetics test is used at all stages of the drug's life cycle. In the 
development of dosage form comparative dissolution kinetics test allows 
to assess the correctness of technological techniques, and thereby 
increase the probability of positive results for future studies of 
bioequivalence. In addition to routine quality control tests, comparative 
dissolution tests have been used to waive bioequivalence requirements 
(biowaivers) for lower strengths of a dosage form [1].  
When planning the design of the experiment, it is necessary to 
gather information on the structure of the API molecule, the acid-
basic properties, solubility, stability in dissolution media, the class 
according to the biopharmaceutical classification system (BSC). For 
the quantitative determination of the concentration of API that has 
been converted into a solution, developed and validated a method is 
very important. Almost for comparative dissolution kinetics test has 
been used spectrophotometry and HPLC. Among the disadvantages 
of spectrophotometry, low selectivity, low sensitivity and relatively 
high variability of the results of the analysis can be noted. Therefore, 
the advantage is provided by HPLC. 
There is an HPLC method described for determination of bisoprolol 
in pharmaceutical preparations [2-5]. However, those methods are 
not developed for the determination of bisoprolol in dissolution 
studies while the dissolution profile of bisoprolol and enalapril from 
the combination drug product has not hitherto been reported in the 
literature. In order to elucidate the dissolution profiles bisoprolol 
and enalapril, a validated HPLC method is required for 
determination of bisoprolol from tablets in dissolution matrix.  
Bisoprolol is a medicines most commonly used for heart diseases, 
the beta blocker family of medications and is of the β1 selective type. 
Bisoprolol is beneficial in the treatment for high blood pressure 
(hypertension), reduced blood flow to the heart (cardiac 
ischemia); congestive heart failure, and preventive treatment before and 
primary treatment after heart attacks decreasing the chances of 
recurrence. The chemical name is 1-[4-[[2-(1-Methylethoxy) 
ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol. 
 
Fig. 1: The chemical structures of of bisoprolol 
 
Its 
structure is shown in fig. 1. 
 
Therefore, the aim of this study was to develop and validate an 
efficient HPLC method for determination of bisoprolol and to 
introduce the dissolution profiles of tablets which contain bisoprolol 
and enalapril. Moreover, this new method could also be used for the 
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routine analysis of bisoprolol in pharmaceutical dosage forms, 
provided it is completely validated and rapid. The present method 
was simple, sensitive, and selective and developed with low-cost 
solvent in the mobile phase and simple standard preparation and 
separation were done at shorter run time and all parameters were 
validated according to ICH guidelines [6]. 
In vitro dissolution of bisoprolol containing tablets were performed 
to validate the suitability of the proposed method. 
MATERIALS AND METHODS 
Chemicals  
Standard bisoprolol and enalapril were supplied by Refik Saydam 
National Public Health Agency. Methanol and phosphate buffer 
solution were of HPLC grade from Merck (Darmstadt, Germany) and 
all other reagents were analytical grade. Water obtained from the 
Milli-Q water system (Barnstead, USA) was used for the preparation 
of buffer and other aqueous solutions. Experimental tablets 
containing 5 mg of enalapril and 2.5 mg of bisoprolol were 
developed by Prof. Kachrimanis Kyriakos (Department of 
Pharmaceutical Technology, Aristotle University of Thessaloniki, 
School of Pharmacy, Thessaloniki, Greece). 
Preparation of strock solution 
Standard stock solutions of bisoprolol were prepared separately by 
dissolving 50 μg of bisoprolol fumarate in 50 ml appropriate solvent. 
These solutions were prepared freshly every week, during method 
development and application period.  
Preparation of calibration standards 
Calibration standards for bisoprolol (as fumarate salt) (1.25, 2.0, 3.0, 
4.0, 10.0, 20.0, 30.0, 40 and 50.0 μg ml-1) were daily prepared from 
standard stock solutions by appropriate dilution processes using 
mobile phase.  
Instrumentation  
The HPLC system consisted of Agilent 1260. A C18 column (Hi Qsil C18, 5 
μm, 4.6х250 mm) was used for separation and quantification. The 
mobile phase consisted of methanol: phosphate buffer solution (65:35, 
v/v) and was filtered through a 0.45 μm filter and degassed before use. 
The injection volume was 300 μL and the ultraviolet detector was set at 
225 nm. Analyses were run at a flow rate of 1.0 ml/min at an ambient 
temperature (25 °C). The peak area was integrated automatically by 
using Empower® software. Under these conditions, bisoprolol was 
eluted at 4.75 min. Total run time was shorter than 6 min.  
In vitro dissolution studies  
In vitro dissolution of twelve tablets containing bisoprolol and 
enalapril was performed using buffer solutions (pH 1.2; 4.5; 6.8) as 
the dissolution media at 50 rpm using an USP Apparatus II. The 
dissolution study was carried out in a 900 ml volume of buffer 
solution at 37 °C (±0.5) using the paddle method. One ml of sample 
was withdrawn and replaced with fresh dissolution medium at the 
time intervals of 5, 15, 30, 45 min. The concentrations of bisoprolol 
in samples were determined by the proposed HPLC method.  
According to the FDA Guidance (Qui, Xu 2007) not less than 85% of 
the active ingredients of the labeled claim should be dissolved 
within 30 min.  
Analytical method validation 
Once the chromatographic and the experimental conditions were 
established, the method was validated by the determination of the 
following parameters such linearity range, sensitivity, repeatability, 
precision, accuracy, and specificity, as per ICH Q2 (R1) guidelines [6-8]. 
System suitability parameters 
The chromatographic systems used for analysis must pass system 
suitability before going to start the experiment. At first HPLC system 
is stabilized for forty minutes. Inject blank preparation (single 
injection) and standard preparation (six replicates) and record the 
chromatograms to evaluate the system suitability parameters such 
as tailing factor (NMT 1.5), theoretical plate count (NLT 3000) and 
retention time. The % RSD for the peak area of six replicate 
injections of bisoprolol fumarate standard NMT 2.0. The parameters 
such as tailing factor, % RSD and theoretical plates were studied. 
Linearity 
A standard stock solution of the bisoprolol fumarate (0.1 mg/ml) was 
prepared with the same solvent. To study the linearity range of drugs, 
serial dilutions were made from a standard stock solution in the range of 
25-200% of the nominal concentrations of bisoprolol in the test solution. 
Specificity  
Specificity of an analytical method is its ability to measure accurately 
and specifically the analyte of interest without interference from 
placebo and degradation products. The specificity of the method was 
established by injecting blank, placebo and standard solution in 
triplicate and recording the chromatograms. 
Precision 
The precision of the method was determined by repeatability 
(intraday) and intermediate precision (interday). Repeatability was 
determined by performing repeated analysis of the same working 
solution of bisoprolol fumarate on the same day, under the same 
experimental conditions. The intermediate precision of the method 
was assessed by carrying out the analysis on different days and also 
by another analyst performing the analysis in the same laboratory 
(between-analysts). 
Accuracy 
The accuracy of a method is defined as the closeness of a measured 
value to the true value. The recovery studies were carried out at 25-
200 % of the target level in the tablet in triplicate each in the 
presence of placebo. 
RESULTS AND DISCUSSION 
Optimization of chromatographic conditions  
Literature survey revealed, RP-HPLC method was developed for 
determination of bisoprolol fumarate in tablets. The mobile phase was a 
mixture of methanol: acetonitrile: 45 mmol potassium dihydrogen 
phosphate buffer (30:25:45) at pH 3.0 and 0.3 ml/min. The stationary 
phase used was a SB-C18Nucleosil column (125×4 mm). The UV 
detection was performed at 225 nm. The method was validated as tar as 
linearity, limit of detection, limit of quantification, precision, accuracy, 
recovery and system suitability. The calibration graph was linear in the 
concentration range 0.3-10μg/ml. The assay proved to be sensitive, 
specific and reproducible. The method was applied for the determination 
of bisoprolol in tablets and in a bioequivalence study [2]. However, this 
method is for analysis of bisoprolol im monomedicine and this method is 
not developed for the determination of bisoprolol in dissolution studies 
while the dissolution profile of bisoprolol and enalapril from the 
combination drug product has not hitherto been reported in the 
literature. In order to elucidate the dissolution profiles bisoprolol and 
enalapril, a validated HPLC method is required for determination of 
bisoprolol from tablets in dissolution matrix.  
In the present study due to the relative apolar properties of 
bisoprolol and enalapril, a reversed phase HPLC system was used to 
analyze both compounds with a sufficient separation and fine peak 
shapes within a short analysis time. The chromatographic 
separation was done with various trails using different conditions. 
Based on theoretical plates, peak shape and back pressure, the 
column was selected. Finally, the chromatographic separation was 
carried out using C18 column (Hi Qsil C18, 5 μm, 4.6х250 mm ) by 
trying various mobile phase [9-29]. After the initial experiments, the 
optimum conditions were found to be the mobile phase of methanol: 
phosphate buffer solution (65:35, v/v) mixture pumped at 1.0 
ml/min flow rate and 225 nm UV detection wavelength, which 
ensured the identification of both APIs insufficient intensity. Under 
the optimum conditions, bisoprolol was eluted at 4.75 min. The 
optimized chromatographic conditions are tabulated in table 1. 
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Table 1: Optimized chromatographic conditions and system suitability parameters 
Parameter Chromatographic conditions 
Instrument Agilent 1260 
Column Hi Qsil C18, 5 μm, 4.6х250 mm 
Mobile phase Methanol: phosphate buffer solution (65:35, v/v) 
Flow rate 1.0 ml/min 
Detection wavelength UV at 225 nm 
Runtime 6 min 
Column temperature 25 ° C 
Volume of the injection loop 300 μl 
Retention time (bisoprolol) 4.75 min 
Representative chromatogram of bisoprolol fumarate in tablets containing bisoprolol and enalapril is presented in fig. 2. 
 
 
Fig. 2: Representative chromatogram of bisoprolol fumarate 
 
Method validation  
The proposed method was validated as to linearity range, sensitivity, 
repeatability, precision, accuracy, and specificity according to the 
ICH guidelines [6]. 
System suitability  
A suitability test was applied to the chromatograms taken under 
optimum conditions to check various parameters such as column 
efficiency (plates), peak tailing, retention factor, and resolution. 
Suitable resolution (>2) and column efficiency (>1500 for both 
compounds) were achieved for the analysis method. The peak 
symmetries for both compounds were<1.2, whereas the capacity 
factors were>1.5. The analysis time was shorter than 6 min.  
Linearity range  
Calibration curve rеpresenting the rеlation betwеen the 
concеntrations of drugs versus the peak area were constructеd. In 
triplicatе run from which the linear regression equation was 
calculated. The results obtained were procеssed by the least squares 
method. The correlation coefficient of bisoprolol fumarate r2
 
Fig. 3: Linearity on profils of dissolution test at pH 1.2 
 was 
noted more than 0.9991 which states that the method was good 
linear to the concentration versus peak area responses. Results 
indicate high sensitivity of the proposed HPLC method. The 
calibration graph of bisoprolol fumarate is presented in fig. 3-5 and 
characteristics of the linear dependence of bisoprolol fumarate are 
listed in table 1. 
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Fig. 4: Linearity on profils of dissolution test at pH 4.5 
 
 
Fig. 5: Linearity on profils of dissolution test at pH 6.8 
 
Table 2: Characteristics of the linear dependence of bisoprolol fumarate 
рН Concentration range (mg/ml) Regression equation R Compliance with eligibility criteria 2 
1.2 0.625–3.750 y=457.6180x-20.6900 0.9993 Corresponds 
4.5 0.625–5.000 y = 446.9561 x-25.2057 0.9991 Corresponds 
6.8 0.625–5.000 y = 426.0197 x+13.2602 0.9992 Corresponds 
 
A linear relationship between the concentration and the area of 
chromatographic peaks of bisoprolol in the range of 0.625 mg/ml-
5.000 mg/ml (3.750 mg/ml at pH 1.2) was established (table 2). 
Requirements for linear dependency parameters are performed in 
this case throughout the range of application of the technique. 
Linearity studies were conducted in a wide range of concentrations 
(25-200% at pH 4.5 and 6.8, 25-150% at pH 1.2) 
Specificity 
Specificity was carried out by evaluation of blank, standard and 
sample injections. The resultant chromatograms of blank, standard 
and sample were compared, the correlation was good between 
standard and sample and no interference of excipients in blank with 
drug was observed. The specificity results are tabulated in table 3. 
 
Table 3: Specificity study 
Name of the solution Retention time (tR) min 
mobile phase No peaks 
placebo No peaks 
bisoprolol fumarate  4.75 
Another API (enalapril) 5.33 
 
The representative chromatograms (fig. 6-11) show no other peaks 
in retention time of bisoprolol and enalapril and retention times did 
not change. In addition, when the solution prepared from the blank 
tablet was injected into the HPLC system, no co-eluting peaks were 
obtained at the retention time of bisoprolol and enalapril. Based on 
these results, the proposed methods can be considered selective. 
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Fig. 6: Representative chromatogram of bisoprolol fumarate under conditions of study of dissolution kinetics at pH 1.2 (timing-15 min) 
 
 
Fig. 7: Representative chromatogram of bisoprolol fumarate under conditions of study of dissolution kinetics at pH 1.2 (timing-30 min) 
 
 
Fig. 8: Representative chromatogram of bisoprolol fumarate under conditions of study of dissolution kinetics at pH 4.5 (timing-15 min) 
 
 
Fig. 9: Representative chromatogram of bisoprolol fumarate under conditions of study of dissolution kinetics at pH 4.5 (timing-30 min) 
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Fig. 10: Representative chromatogram of bisoprolol fumarate under conditions of study of dissolution kinetics at pH 6.8 (timing-15 min) 
 
 
Fig. 11: Representative chromatogram of bisoprolol fumarate under conditions of study of dissolution kinetics at pH 6.8 (timing–30 min) 
 
Commonly used tablet excipients did not interfere with this method. 
It shows that the method is specific. 
Accuracy and precision 
System precision is shown in table 4. Intra-day and inter-day % RSD 
values lower than 2% clearly assuring that this method was found to 
be fairly precise and reproducible (table 5). Regarding accuracy, a 
known amount of the standard drug was added to the fixed amount of 
preanalyzed sample solution. % recovery was calculated by comparing 
the area before and after the addition of the standard drug. The 
standard addition method was performed at 25-200 % levels 
concentrations. The high value of recoveries obtained for bisoprolol 
indicates that the proposed method was found to be accurate. 
In vitro dissolution studies  
The average percentage of drugs released as detected by the 
proposed HPLC method after in vitro dissolution of tablets 
containing combination drug product are depicted in fig. 12-14. 
  
Table 4: Results of system precision (n=5) 
Sample Concentration (μg/ml) Peak area Injection no. RSD, % 





n is number of determinations, RSD is relative standard deviation 
 
Table 5: Intra-day and Inter-day precision data of bisoprolol fumarate (n=3) 
Day Intra-day precision Inter-day precision 
Mean RSD % Mean RSD % 
1 99.42 0.211 100.18 0.264 
2 100.11 0.347 99.93 0.230 
3 100.62 0.246 100.45 0.381 
n is number of determinations, RSD is relative standard deviation 
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Fig. 12: In vitro dissolution profiles of bisoprolol at pH 1.2 mean±SD, n=3 
 
 
Fig. 13: In vitro dissolution profiles of bisoprolol at pH 4.5 mean±SD, n=3 
 
 
Fig. 14: In vitro dissolution profiles of bisoprolol at pH 6.8 mean±SD, n=3 
 
The point «15 min» is critical and decisive. Medicine is considered 
very quick soluble when at least 85% of the active substance 
dissolves in 15 min, quickly soluble-when at least 85% of the active 
substance dissolves in 30 min. 
Dissolution testing should be carried out under mild test conditions, 
basket method at 50/100 rpm or paddle method at 50/75 rpm, at 15-
minute intervals, to generate a dissolution profile. For rapidly-dissolving 
products, generation of an adequate profile sampling at 5-or 10-minute 
intervals may be necessary. For highly soluble and rapidly dissolving 
drug products (BCS classes 1 and 3), a single-point dissolution test 
specification of NLT 85% (Q=80%) in 60 min or less is sufficient as a 
routine quality control test for batch-to-batch uniformity. 
As can be seen from fig. 12-14, in the medium with pH 1.2 release of 
bisoprolol from tablets in 5 min is 38.42%, and after 15 min-85.51%, in 
medium with pH 4.5 the release of bisoprolol from tablets in 5 min 
makes 59.78%, and after 15 min-103.71%; in a medium with pH 6.8, the 
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release of bisoprolol from tablets in 5 min is 61.29%, and after 15 min-
85.90%. The results indicated that the drug release from the matrix 
tablets followed zero order kinetics. To evaluate the drug release 
mechanism from the matrix tablets plots of percent drug released verses 
square root of time as per Higuchi’s equation were constructed. These 
plots were found to be linear with all the tablets with correlation 
coefficient values in the range 0.9991 to 0.9993 indicating that the drug 
release from the tablet was controlled. The dissolution pattern complies 
with the FDA standards, indicating the suitability of the proposed 
method for the dissolution study of bisoprolol.  
Compared to the previous method [2], this method is selective, 
simple, sensitive, and separation was done at shorter run time and in 
the presence of another API in tablets (enalapril). 
The studies conducted have shown that bisoprolol can be referred to 
class І of BSC, i.e. substances with a high biopharmaceutical 
solubility. It will allow conducting comparative studies in vitro to 
confirm the equivalence of drugs. 
CONCLUSION  
The RP-HPLC method for estimation of bisoprolol was found to be 
simple, sensitive, precise and accurate. The present study of method 
development and method validation was as per ICH guidelines, and 
it meets the specific acceptance criteria. Based on the results, it can 
be concluded that there is no other co-eluting peak with the main 
peaks and that the method is specific for estimation of bisoprolol. 
The proposed method has linear response in the stated range and is 
accurate and precise. The developed method can also be 
conveniently adopted for dissolution testing of tablets containing 
bisoprolol. This method can help research studies, quality control 
and routine analysis, where economy and time were essential. 
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